JPWO2020203755A1 - - Google Patents

Info

Publication number
JPWO2020203755A1
JPWO2020203755A1 JP2021511988A JP2021511988A JPWO2020203755A1 JP WO2020203755 A1 JPWO2020203755 A1 JP WO2020203755A1 JP 2021511988 A JP2021511988 A JP 2021511988A JP 2021511988 A JP2021511988 A JP 2021511988A JP WO2020203755 A1 JPWO2020203755 A1 JP WO2020203755A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021511988A
Other languages
Japanese (ja)
Other versions
JPWO2020203755A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020203755A1 publication Critical patent/JPWO2020203755A1/ja
Publication of JPWO2020203755A5 publication Critical patent/JPWO2020203755A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • G01N33/723Glycosylated haemoglobin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L9/00Compositions of homopolymers or copolymers of conjugated diene hydrocarbons
    • C08L9/06Copolymers with styrene
    • C08L9/08Latex
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545Synthetic resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2021511988A 2019-03-29 2020-03-27 Withdrawn JPWO2020203755A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019067785 2019-03-29
PCT/JP2020/013989 WO2020203755A1 (ja) 2019-03-29 2020-03-27 免疫測定試薬及び免疫測定方法

Publications (2)

Publication Number Publication Date
JPWO2020203755A1 true JPWO2020203755A1 (https=) 2020-10-08
JPWO2020203755A5 JPWO2020203755A5 (https=) 2022-01-25

Family

ID=72668475

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021511988A Withdrawn JPWO2020203755A1 (https=) 2019-03-29 2020-03-27

Country Status (8)

Country Link
US (1) US20220187323A1 (https=)
EP (1) EP3951389A4 (https=)
JP (1) JPWO2020203755A1 (https=)
KR (1) KR20210146915A (https=)
CN (1) CN113677993A (https=)
SG (1) SG11202110318YA (https=)
TW (1) TW202102850A (https=)
WO (1) WO2020203755A1 (https=)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210723A (en) * 1976-07-23 1980-07-01 The Dow Chemical Company Method of coupling a protein to an epoxylated latex
JPS55110118A (en) * 1979-02-20 1980-08-25 Dow Chemical Co Method of combining epoxylated latex with protein and product formed therefrom
FR2450263A1 (fr) * 1979-02-28 1980-09-26 Dow Chemical Co Procede pour coupler une proteine sur un latex portant des groupes epoxyde et produits obtenus par ce procede
JPS61247966A (ja) * 1985-04-25 1986-11-05 Daikin Ind Ltd 抗原−抗体反応測定用試薬
JP2590330B2 (ja) * 1987-02-17 1997-03-12 三菱化学株式会社 抗原抗体反応の測定法
JP2677753B2 (ja) * 1993-07-22 1997-11-17 株式会社エスアールエル 凝集イムノアッセイ法
JPH0933528A (ja) * 1995-07-18 1997-02-07 Nissui Pharm Co Ltd 免疫分析用反応試薬及びその製造方法
FR2781486B1 (fr) * 1998-07-10 2000-09-08 Atochem Elf Sa Polymerisation en emulsion en presence d'un radical libre stable
JP2001074742A (ja) * 1999-09-06 2001-03-23 Jsr Corp ラテックス免疫比濁法および測定キット
JP2001153869A (ja) * 1999-11-29 2001-06-08 Nippon Paint Co Ltd 診断試薬用ラテックス、その製造方法、および診断試薬
EP2298312B1 (en) * 2003-10-31 2018-09-26 Molecular Probes Inc. Fluorinated resorufin compounds and their application in detecting hydrogen peroxide
EP1877553B1 (en) * 2005-05-02 2011-01-19 ANP Technologies, Inc. Polymer conjugate enhanced bioassays
JP2007003411A (ja) * 2005-06-24 2007-01-11 Sekisui Chem Co Ltd ヘモグロビンA1cの測定方法及びヘモグロビンA1c測定用キット
EP2049902A4 (en) * 2006-07-28 2010-09-01 Biosite Inc DEVICES AND METHODS FOR PERFORMING BINDING TESTS WITH RECEIVERS USING MAGNETIC PARTICLES
CA2721982A1 (en) * 2008-04-30 2009-11-05 Novartis Ag Assay for pathogenic conformers
TWI509248B (zh) * 2009-06-30 2015-11-21 Sekisui Medical Co Ltd KL-6 detection of immunoassay reagents
JP6004516B2 (ja) * 2012-03-22 2016-10-12 積水メディカル株式会社 ヘモグロビン類分離用カラム充填剤及びその製造方法
JP6216298B2 (ja) 2014-08-29 2017-10-18 株式会社日立ハイテクノロジーズ 自動分析装置及びそれを用いた分析方法
SG11201706790TA (en) * 2015-02-25 2017-09-28 Sekisui Medical Co Ltd L-fabp immunoassay method and assay reagent used in said method
KR102695682B1 (ko) * 2015-04-07 2024-08-14 사빅 글로벌 테크놀러지스 비.브이. 기계적 안정성이 있는 플루오로중합체계 라텍스를 생산하는 방법
JP6731311B2 (ja) 2016-08-09 2020-07-29 株式会社日立ハイテク 自動分析装置
CN107213928B (zh) * 2017-05-31 2019-06-11 深圳市海拓华擎生物科技有限公司 一种微流控芯片及其制备方法

Also Published As

Publication number Publication date
US20220187323A1 (en) 2022-06-16
EP3951389A1 (en) 2022-02-09
KR20210146915A (ko) 2021-12-06
TW202102850A (zh) 2021-01-16
EP3951389A4 (en) 2022-12-14
WO2020203755A1 (ja) 2020-10-08
SG11202110318YA (en) 2021-10-28
CN113677993A (zh) 2021-11-19

Similar Documents

Publication Publication Date Title
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112021017728A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021017310A2 (https=)
BR112021018484A2 (https=)
BR112021017949A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210712

A625 Written request for application examination (by other person)

Free format text: JAPANESE INTERMEDIATE CODE: A625

Effective date: 20221213

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20230810